WILMINGTON, Mass.--(BUSINESS WIRE)--AdvanSource Biomaterials Corporation (NYSE Alternext US: ASB) was approved by shareholders as the new Company name at the CardioTech International, Inc. (formerly AMEX: CTE) annual meeting held at the Company’s corporate headquarters on October 15, 2008. The Company, a developer of advanced polymer materials for medical device design and development, subsequently announced that its American Exchange stock symbol will change to NYSE Alternext US: ASB upon US market opening as of October 16, 2008.
